Is DHEA-S produced mainly by the adrenal glands and a marker of adrenal androgen output?

Dehydroepiandrosterone sulfate (DHEA-S) is the most abundant circulating steroid hormone in humans and serves as a critical physiological indicator of adrenal health. In women, its levels are particularly useful for distinguishing between adrenal and ovarian androgen contributions.

Clinical and physiological evidence

DHEA-S is synthesized almost exclusively within the zona reticularis of the adrenal cortex. Research confirms that while other tissues like the ovaries contribute to various androgen pools, the adrenal glands are the dominant source of systemic DHEA-S. For a 50-year-old female, DHEA-S levels remain a primary tool for assessing adrenal secretory activity, as the adrenal contribution persists even after the decline of ovarian function during menopause.

Unlike its precursor DHEA, which has a short half-life and fluctuates significantly throughout the day, DHEA-S has a long half-life and stable serum concentrations. This stability makes it a highly reliable biomarker in clinical practice. For example, in patients with adrenal incidentalomas, DHEA-S levels below 40 mcg/dL provide 84% specificity for diagnosing autonomous cortisol secretion. In broader diagnostic contexts, meta-analyses show that DHEA-S levels between 60–70 mcg/dL offer approximately 82% sensitivity and specificity for identifying mild autonomous cortisol secretion.

Mechanistic explanations

The production of DHEA-S is a highly regulated enzymatic process centered in the adrenal glands:

• Enzymatic conversion: The enzyme SULT2A1, primarily located in the adrenal zona reticularis, catalyzes the sulfation of DHEA into DHEA-S.
• Cofactor dependency: This process requires the sulfate donor PAPS. The critical role of this adrenal pathway is evidenced by the fact that mutations in the PAPSS2 gene (essential for PAPS synthesis) result in nearly undetectable systemic DHEA-S levels.
• Androgen precursors: DHEA-S acts as a large reservoir that can be converted back into DHEA and subsequently into potent androgens like testosterone or estrogens in peripheral tissues, depending on the local enzymatic environment.

Bottom line

DHEA-S is a clinically validated marker of adrenal androgen output, primarily produced in the adrenal zona reticularis. Its long half-life and stable serum levels make it a superior diagnostic tool for evaluating adrenal function and androgen excess compared to other androgenic steroids.